- Home
- MRK vs SPGI Comparison
MRK vs SPGI Comparison
Compare MRK & SPGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- SPGI
- Stock Information
- Founded
- MRK 2000
- SPGI 1860
- Country
- MRK United States
- SPGI United States
- Employees
- MRK N/A
- SPGI N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- SPGI Finance: Consumer Services
- Sector
- MRK Health Care
- SPGI Finance
- Exchange
- MRK Nasdaq
- SPGI Nasdaq
- Market Cap
- MRK 198.5B
- SPGI 168.3B
- IPO Year
- MRK N/A
- SPGI N/A
- Fundamental
- Price
- MRK $80.44
- SPGI $559.11
- Analyst Decision
- MRK Buy
- SPGI Buy
- Analyst Count
- MRK 15
- SPGI 13
- Target Price
- MRK $111.14
- SPGI $612.67
- AVG Volume (30 Days)
- MRK 12.4M
- SPGI 1.2M
- Earning Date
- MRK 07-29-2025
- SPGI 07-31-2025
- Dividend Yield
- MRK 4.03%
- SPGI 0.69%
- EPS Growth
- MRK 20.41
- SPGI 23.49
- EPS
- MRK 6.49
- SPGI 13.00
- Revenue
- MRK $63,616,000,000.00
- SPGI $14,700,000,000.00
- Revenue This Year
- MRK $2.27
- SPGI $7.58
- Revenue Next Year
- MRK $5.68
- SPGI $7.09
- P/E Ratio
- MRK $12.39
- SPGI $43.00
- Revenue Growth
- MRK 1.82
- SPGI 10.73
- 52 Week Low
- MRK $73.31
- SPGI $427.14
- 52 Week High
- MRK $120.30
- SPGI $566.13
- Technical
- Relative Strength Index (RSI)
- MRK 48.77
- SPGI 68.31
- Support Level
- MRK $78.65
- SPGI $552.51
- Resistance Level
- MRK $81.32
- SPGI $566.42
- Average True Range (ATR)
- MRK 2.11
- SPGI 10.11
- MACD
- MRK -0.29
- SPGI 2.67
- Stochastic Oscillator
- MRK 47.20
- SPGI 87.19
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.